Inflammatory bowel disease in 2024 and beyond
Aliment Pharmacol Ther
.
2024 Nov;60(9):1164-1165.
doi: 10.1111/apt.18295.
Authors
Richard B Gearry
1
2
,
Cynthia H Seow
3
,
Sreedhar Subramanian
4
Affiliations
1
Department of Medicine, University of Otago Christchurch, Christchurch, New Zealand.
2
Department of Gastroenterology, Christchurch Hospital, Christchurch, New Zealand.
3
Division of Gastroenterology and Hepatology, Departments of Medicine and Community Health Sciences, University of Calgary, Calgary, Alberta, Canada.
4
Department of Gastroenterology, Cambridge University Hospital NHS Foundation Trust, Cambridge, UK.
PMID:
39403063
DOI:
10.1111/apt.18295
No abstract available
Publication types
Editorial
MeSH terms
Humans
Inflammatory Bowel Diseases*